drugset / Trial / NCT00086359

Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV

NCT00086359

RandomizedParallel-groupOpen-labelPrevention

Summary

Pregnant women infected with HIV who take anti-HIV medications during pregnancy lower the risk of passing HIV to their infants. This study will compare how well two different combinations of anti-HIV medications control HIV in pregnancy, and whether these combinations of drugs are effective in preventing HIV from being transmitted from a pregnant woman to her baby. The two combinations are abacavir/lamivudine/zidovudine (ABC/3TC/ZDV) and zidovudine/lamivudine (ZDV/3TC) plus lopinavir/ritonavir (LPV/RTV).

Timeline

Start
2004-07
Primary completion
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Abacavir Other / unclassified Oral
Subject Lopinavir Other / unclassified Oral
Subject Ritonavir Other / unclassified Oral
Background Lamivudine Other / unclassified Oral
Background Zidovudine Small molecule Oral